{
  "fullName": "Krishna Ella",
  "slug": "krishna-ella",
  "title": "MD",
  "specialty": "Vaccinology - Covaxin development",
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Krishna Ella is an Indian scientist and entrepreneur. He is the co-founder and Executive Chairman of Bharat Biotech, a biotechnology company known for developing Covaxin, India's first indigenous COVID-19 vaccine, in collaboration with the Indian Council of Medical Research (ICMR). Bharat Biotech was also involved in the development of ROTAVAC, a vaccine against rotavirus, in collaboration with Department of Biotechnology (DBT), Government of India, and international partners, including the Rotavirus Vaccine Development Program (RVDP) of PATH and the National Institutes of Health (NIH), USA; and Typbar TCV, a typhoid conjugate vaccine.\nElla worked as a research faculty member at the Medical University of South Carolina in Charleston after earning his Ph.D. from the University of Wisconsin–Madison. In 2022, Ella and his wife, Suchitra Ella, received the Padma Bhushan, India's third-highest civilian award, for their contributions to trade and industry.",
  "aiSummary": "Krishna Ella is a vaccinology - covaxin development specialist with an H-index of 110 at Bharat Biotech (Faculty). Has been published in The Lancet Infectious Diseases, The Lancet, iScience. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Bharat Biotech"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Bharat Biotech",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Vaccinology - Covaxin development"
  ],
  "knowsAbout": [
    "Covaxin development"
  ],
  "citations": [
    {
      "title": "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial",
      "journal": "The Lancet Infectious Diseases",
      "year": 2021,
      "citationCount": 433,
      "doi": "10.1016/s1473-3099(20)30942-7",
      "sourceUrl": "https://doi.org/10.1016/s1473-3099(20)30942-7",
      "verified": true
    },
    {
      "title": "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial",
      "journal": "The Lancet Infectious Diseases",
      "year": 2021,
      "citationCount": 360,
      "doi": "10.1016/s1473-3099(21)00070-0",
      "sourceUrl": "https://doi.org/10.1016/s1473-3099(21)00070-0",
      "verified": true
    },
    {
      "title": "Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial",
      "journal": "The Lancet",
      "year": 2021,
      "citationCount": 358,
      "doi": "10.1016/s0140-6736(21)02000-6",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(21)02000-6",
      "verified": true
    },
    {
      "title": "Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study",
      "journal": "Clinical Infectious Diseases",
      "year": 2015,
      "citationCount": 199,
      "doi": "10.1093/cid/civ295",
      "sourceUrl": "https://doi.org/10.1093/cid/civ295",
      "verified": true
    },
    {
      "title": "Protective efficacy of Zika vaccine in AG129 mouse model",
      "journal": "Scientific Reports",
      "year": 2017,
      "citationCount": 101,
      "doi": "10.1038/srep46375",
      "sourceUrl": "https://doi.org/10.1038/srep46375",
      "verified": true
    },
    {
      "title": "Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation",
      "journal": "iScience",
      "year": 2021,
      "citationCount": 92,
      "doi": "10.1016/j.isci.2021.102298",
      "sourceUrl": "https://doi.org/10.1016/j.isci.2021.102298",
      "verified": true
    },
    {
      "title": "Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques",
      "journal": "Nature Communications",
      "year": 2021,
      "citationCount": 87,
      "doi": "10.1038/s41467-021-21639-w",
      "sourceUrl": "https://doi.org/10.1038/s41467-021-21639-w",
      "verified": true
    },
    {
      "title": "Expression of phospholipase D isoforms in mammalian cells",
      "journal": "Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids",
      "year": 1999,
      "citationCount": 83,
      "doi": "10.1016/s1388-1981(99)00095-5",
      "sourceUrl": "https://doi.org/10.1016/s1388-1981(99)00095-5",
      "verified": true
    },
    {
      "title": "Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model",
      "journal": "iScience",
      "year": 2021,
      "citationCount": 82,
      "doi": "10.1016/j.isci.2021.102054",
      "sourceUrl": "https://doi.org/10.1016/j.isci.2021.102054",
      "verified": true
    },
    {
      "title": "Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a, double-blind, randomised, controlled phase 3 trial",
      "journal": "Unknown Journal",
      "year": 2021,
      "citationCount": 79,
      "doi": "10.1101/2021.06.30.21259439",
      "sourceUrl": "https://doi.org/10.1101/2021.06.30.21259439",
      "verified": true
    },
    {
      "title": "Characterization of <i>Saccharomyces cerevisiae</i> deficient in expression of phospholipase D",
      "journal": "Biochemical Journal",
      "year": 1996,
      "citationCount": 73,
      "doi": "10.1042/bj3140015",
      "sourceUrl": "https://doi.org/10.1042/bj3140015",
      "verified": true
    },
    {
      "title": "A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains",
      "journal": "The Journal of Infectious Diseases",
      "year": 2015,
      "citationCount": 67,
      "doi": "10.1093/infdis/jiv023",
      "sourceUrl": "https://doi.org/10.1093/infdis/jiv023",
      "verified": true
    },
    {
      "title": "Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells",
      "journal": "Journal of Cellular Physiology",
      "year": 1998,
      "citationCount": 64,
      "doi": "10.1002/(sici)1097-4652(199802)174:2<261::aid-jcp13>3.0.co;2-f",
      "sourceUrl": "https://doi.org/10.1002/(sici)1097-4652(199802)174:2<261::aid-jcp13>3.0.co;2-f",
      "verified": true
    },
    {
      "title": "Genetic diversity of chikungunya virus, India 2006–2010: Evolutionary dynamics and serotype analyses",
      "journal": "Journal of Medical Virology",
      "year": 2012,
      "citationCount": 52,
      "doi": "10.1002/jmv.23187",
      "sourceUrl": "https://doi.org/10.1002/jmv.23187",
      "verified": true
    },
    {
      "title": "Characterization of a regulated form of phospholipase D in the yeast <i>Saccharomyces cerevisiae</i>",
      "journal": "Biochemical Journal",
      "year": 1995,
      "citationCount": 50,
      "doi": "10.1042/bj3070799",
      "sourceUrl": "https://doi.org/10.1042/bj3070799",
      "verified": true
    },
    {
      "title": "A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg",
      "journal": "Vaccine",
      "year": 2007,
      "citationCount": 49,
      "doi": "10.1016/j.vaccine.2007.03.051",
      "sourceUrl": "https://doi.org/10.1016/j.vaccine.2007.03.051",
      "verified": true
    },
    {
      "title": "Coronavirus Vaccine: Light at the End of the Tunnel",
      "journal": "Indian Pediatrics",
      "year": 2020,
      "citationCount": 43,
      "doi": "10.1007/s13312-020-1812-z",
      "sourceUrl": "https://doi.org/10.1007/s13312-020-1812-z",
      "verified": true
    },
    {
      "title": "Activations of mitogen-activated protein kinases and phospholipase D in A7r5 vascular smooth muscle cells.",
      "journal": "Journal of Biological Chemistry",
      "year": 1994,
      "citationCount": 42,
      "doi": "10.1016/s0021-9258(17)31585-5",
      "sourceUrl": "https://doi.org/10.1016/s0021-9258(17)31585-5",
      "verified": true
    },
    {
      "title": "Immunomodulatory activity of biopolymeric fraction BOS 2000 from <i>Boswellia serrata</i>",
      "journal": "Phytotherapy Research",
      "year": 2007,
      "citationCount": 41,
      "doi": "10.1002/ptr.2320",
      "sourceUrl": "https://doi.org/10.1002/ptr.2320",
      "verified": true
    },
    {
      "title": "Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report",
      "journal": "Unknown Journal",
      "year": 2020,
      "citationCount": 38,
      "doi": "10.1101/2020.12.21.20248643",
      "sourceUrl": "https://doi.org/10.1101/2020.12.21.20248643",
      "verified": true
    },
    {
      "title": "Utilization of alcohols by plant and mammalian phospholipase D",
      "journal": "IUBMB Life",
      "year": 1997,
      "citationCount": 37,
      "doi": "10.1080/15216549700201761",
      "sourceUrl": "https://doi.org/10.1080/15216549700201761",
      "verified": true
    },
    {
      "title": "Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants",
      "journal": "Scientific Reports",
      "year": 2022,
      "citationCount": 34,
      "doi": "10.1038/s41598-022-16097-3",
      "sourceUrl": "https://doi.org/10.1038/s41598-022-16097-3",
      "verified": true
    },
    {
      "title": "RLJ-NE-299A: A new plant based vaccine adjuvant",
      "journal": "Vaccine",
      "year": 2006,
      "citationCount": 32,
      "doi": "10.1016/j.vaccine.2006.06.036",
      "sourceUrl": "https://doi.org/10.1016/j.vaccine.2006.06.036",
      "verified": true
    },
    {
      "title": "A Fluorescent Assay for Agonist-Activated Phospholipase D in Mammalian Cell Extracts",
      "journal": "Analytical Biochemistry",
      "year": 1994,
      "citationCount": 31,
      "doi": "10.1006/abio.1994.1152",
      "sourceUrl": "https://doi.org/10.1006/abio.1994.1152",
      "verified": true
    },
    {
      "title": "Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study",
      "journal": "The Lancet Infectious Diseases",
      "year": 2022,
      "citationCount": 31,
      "doi": "10.1016/s1473-3099(22)00307-3",
      "sourceUrl": "https://doi.org/10.1016/s1473-3099(22)00307-3",
      "verified": true
    },
    {
      "title": "Effects of Propranolol on Phosphatidate Phosphohydrolase and Mitogen-Activated Protein Kinase Activities in A7r5 Vascular Smooth Muscle Cells",
      "journal": "Cellular Signalling",
      "year": 1998,
      "citationCount": 30,
      "doi": "10.1016/s0898-6568(97)00140-x",
      "sourceUrl": "https://doi.org/10.1016/s0898-6568(97)00140-x",
      "verified": true
    },
    {
      "title": "Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate Formulation",
      "journal": "Molecules",
      "year": 2018,
      "citationCount": 29,
      "doi": "10.3390/molecules23071749",
      "sourceUrl": "https://doi.org/10.3390/molecules23071749",
      "verified": true
    },
    {
      "title": "Characterization of a Sphingomyelinase Activity inSaccharomyces cerevisiae",
      "journal": "Archives of Biochemistry and Biophysics",
      "year": 1997,
      "citationCount": 29,
      "doi": "10.1006/abbi.1997.9897",
      "sourceUrl": "https://doi.org/10.1006/abbi.1997.9897",
      "verified": true
    },
    {
      "title": "Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion InactivatedSARS-CoV-2 Vaccine - BBV152",
      "journal": "Unknown Journal",
      "year": 2020,
      "citationCount": 27,
      "doi": "10.1101/2020.09.09.285445",
      "sourceUrl": "https://doi.org/10.1101/2020.09.09.285445",
      "verified": true
    },
    {
      "title": "Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development",
      "journal": "The Lancet",
      "year": 2014,
      "citationCount": 26,
      "doi": "10.1016/s0140-6736(14)60191-4",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(14)60191-4",
      "verified": true
    },
    {
      "title": "Effects of phorbol ester on phospholipase D and mitogen-activated protein kinase activities in T-lymphocyte cell lines",
      "journal": "Immunology Letters",
      "year": 1996,
      "citationCount": 24,
      "doi": "10.1016/s0165-2478(96)02614-4",
      "sourceUrl": "https://doi.org/10.1016/s0165-2478(96)02614-4",
      "verified": true
    },
    {
      "title": "Remarkable immunogenicity and protective efficacy of BBV152, an inactivated SARS-CoV-2 vaccine in rhesus macaques",
      "journal": "Unknown Journal",
      "year": 2020,
      "citationCount": 22,
      "doi": "10.21203/rs.3.rs-65715/v1",
      "sourceUrl": "https://doi.org/10.21203/rs.3.rs-65715/v1",
      "verified": true
    },
    {
      "title": "Effects of Ara‐C on neutral sphingomyelinase and mitogen‐and stress‐activated protein kinases in T‐lymphocyte cell lines",
      "journal": "IUBMB Life",
      "year": 1996,
      "citationCount": 20,
      "doi": "10.1080/15216549600201313",
      "sourceUrl": "https://doi.org/10.1080/15216549600201313",
      "verified": true
    },
    {
      "title": "Synergistic Effects of Insulin and Phorbol Ester on Mitogen-activated Protein Kinase in Rat-1 HIR Cells",
      "journal": "Journal of Biological Chemistry",
      "year": 1996,
      "citationCount": 18,
      "doi": "10.1074/jbc.271.3.1678",
      "sourceUrl": "https://doi.org/10.1074/jbc.271.3.1678",
      "verified": true
    },
    {
      "title": "Evaluation of Safety and Immunogenicity of an Adjuvanted, TH-1 Skewed, Whole Virion Inactivated SARS-CoV-2 Vaccine - BBV152",
      "journal": "SSRN Electronic Journal",
      "year": 2020,
      "citationCount": 14,
      "doi": "10.2139/ssrn.3737812",
      "sourceUrl": "https://doi.org/10.2139/ssrn.3737812",
      "verified": true
    },
    {
      "title": "Safety and immunogenicity trial of an inactivated SARS-CoV-2 vaccine-BBV152: a phase 1, double-blind, randomised control trial",
      "journal": "Unknown Journal",
      "year": 2020,
      "citationCount": 13,
      "doi": "10.1101/2020.12.11.20210419",
      "sourceUrl": "https://doi.org/10.1101/2020.12.11.20210419",
      "verified": true
    },
    {
      "title": "Phospholipase D Activity in PC12 Cells",
      "journal": "Journal of Biological Chemistry",
      "year": 1997,
      "citationCount": 12,
      "doi": "10.1074/jbc.272.20.12909",
      "sourceUrl": "https://doi.org/10.1074/jbc.272.20.12909",
      "verified": true
    },
    {
      "title": "Immunogenicity and protective efficacy of BBV152: a whole virion inactivated SARS CoV-2 vaccine in the Syrian hamster model",
      "journal": "Research Square (Research Square)",
      "year": 2020,
      "citationCount": 11,
      "doi": "10.21203/rs.3.rs-76768/v1",
      "sourceUrl": "https://doi.org/10.21203/rs.3.rs-76768/v1",
      "verified": true
    },
    {
      "title": "Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (BBV152) in children from 2 to 18 years of age: an open-label, age-de-escalation phase 2/3 study",
      "journal": "Unknown Journal",
      "year": 2021,
      "citationCount": 9,
      "doi": "10.1101/2021.12.28.21268468",
      "sourceUrl": "https://doi.org/10.1101/2021.12.28.21268468",
      "verified": true
    },
    {
      "title": "Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India",
      "journal": "Vaccine",
      "year": 2014,
      "citationCount": 9,
      "doi": "10.1016/j.vaccine.2014.04.072",
      "sourceUrl": "https://doi.org/10.1016/j.vaccine.2014.04.072",
      "verified": true
    },
    {
      "title": "Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine-BBV152: A Phase 1, Double-Blind, Randomised Control Trial",
      "journal": "SSRN Electronic Journal",
      "year": 2020,
      "citationCount": 8,
      "doi": "10.2139/ssrn.3747047",
      "sourceUrl": "https://doi.org/10.2139/ssrn.3747047",
      "verified": true
    },
    {
      "title": "Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies",
      "journal": "Vaccine",
      "year": 2014,
      "citationCount": 8,
      "doi": "10.1016/j.vaccine.2014.05.039",
      "sourceUrl": "https://doi.org/10.1016/j.vaccine.2014.05.039",
      "verified": true
    },
    {
      "title": "Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial",
      "journal": "Unknown Journal",
      "year": 2022,
      "citationCount": 6,
      "doi": "10.1101/2022.01.05.22268777",
      "sourceUrl": "https://doi.org/10.1101/2022.01.05.22268777",
      "verified": true
    },
    {
      "title": "Evaluation of activity of recombinant lysostaphin against isolates of meticillin-resistant Staphylococcus aureus from Indian hospitals",
      "journal": "Journal of Medical Microbiology",
      "year": 2014,
      "citationCount": 5,
      "doi": "10.1099/jmm.0.070557-0",
      "sourceUrl": "https://doi.org/10.1099/jmm.0.070557-0",
      "verified": true
    },
    {
      "title": "Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled <i>In Vitro</i> Expression of <i>Ebolavirus</i> Glycoprotein",
      "journal": "Viral Immunology",
      "year": 2018,
      "citationCount": 4,
      "doi": "10.1089/vim.2017.0122",
      "sourceUrl": "https://doi.org/10.1089/vim.2017.0122",
      "verified": true
    },
    {
      "title": "Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes",
      "journal": "Cells",
      "year": 2024,
      "citationCount": 3,
      "doi": "10.3390/cells13060520",
      "sourceUrl": "https://doi.org/10.3390/cells13060520",
      "verified": true
    },
    {
      "title": "A combination typhoid and non-typhoidal Salmonella polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial",
      "journal": "Nature Medicine",
      "year": 2025,
      "citationCount": 3,
      "doi": "10.1038/s41591-025-04003-z",
      "sourceUrl": "https://doi.org/10.1038/s41591-025-04003-z",
      "verified": true
    },
    {
      "title": "Coronavirus Vaccines: Light at the End of the Tunnel",
      "journal": "Indian Pediatrics",
      "year": 2020,
      "citationCount": 1,
      "doi": null,
      "sourceUrl": "https://openalex.org/W3015908343",
      "verified": true
    },
    {
      "title": "An Ebola vaccine candidate based on controlled expression of antigen through the recombinant adenovirus system",
      "journal": "International Journal of Infectious Diseases",
      "year": 2016,
      "citationCount": 1,
      "doi": "10.1016/j.ijid.2016.02.896",
      "sourceUrl": "https://doi.org/10.1016/j.ijid.2016.02.896",
      "verified": true
    },
    {
      "title": "Vaccines for emerging infections: Chikungunya vaccine",
      "journal": "International Journal of Infectious Diseases",
      "year": 2016,
      "citationCount": 0,
      "doi": "10.1016/j.ijid.2016.02.895",
      "sourceUrl": "https://doi.org/10.1016/j.ijid.2016.02.895",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:20.000Z",
  "openalexId": "https://openalex.org/A5078324189",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/1/13/Krishna_Murthy_Ella.jpg/330px-Krishna_Murthy_Ella.jpg"
}